IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q3 2014 Holdings

Filed 2014-11-14 | 13 holdings | $167.3K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2014-11-25) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
ProsensaACommonN71546100$52.4K6,213,92431.3%
Lombard MedicalCommonG55598109$25.6K3,352,54415.3%
Supernus(SUPN)ACommon868459108$25.0K2,879,32815.0%
PortolaCommon737010108$23.5K930,68214.1%
Dicerna(DRNAUSD)Common253031108$15.0K1,182,1969.0%
AmarinSpons ADR023111206$8.8K8,087,4865.3%
CempraCommon15130J109$7.8K714,2854.7%
ZogenixCommon98978L105$2.7K2,335,2181.6%
RegulusCommon75915K101$2.2K327,3501.3%
Oncogenex PharmaCommon68230A106$1.6K603,7401.0%
HyperionCommon44915N101$1.6K62,5000.9%
AntheraCommon03674U201$832437,9940.5%
Epirus BiopharmaCommon29428P107$567,8960.0%